MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q2
hinzugefügt 08.08.2025
Land |
 Vereinigte Staaten |
IPO-Jahr |
1998 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBALSPB |
Anteile |
14.2 M |
Marktkapitalisierung |
$ 608 M |
EBITDA (LTM) |
$ -8.65 M |
P/E (LTM) |
- |
P/S (LTM) |
5.16 |
EPS (LTM) |
-1.52 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Agilent Technologies
A
|
$ 114.87 | -0.65 % | $ 34.9 B | NYSE,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
Co-Diagnostics
CODX
|
$ 1.63 | -1.21 % | $ 2.17 M | Nasdaq Capital Market | USA |
 |
Castle Biosciences
CSTL
|
$ 24.7 | -1.12 % | $ 686 M | Nasdaq Global Market,SPB | USA |
 |
CareDx, Inc
CDNA
|
$ 21.91 | 0.27 % | $ 1.17 B | Nasdaq Global Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 15.3 | -1.92 % | $ 463 M | Nasdaq Global Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Charles River Laboratories International
CRL
|
$ 166.79 | -2.59 % | $ 8.27 B | NYSE,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Guardant Health
GH
|
$ 83.09 | -6.11 % | $ 10.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 27.12 | -1.53 % | $ 20 B | NYSE |  Niderland |
 |
Illumina
ILMN
|
$ 126.92 | -1.24 % | $ 20.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
Interpace Biosciences
IDXG
|
$ 1.93 | - | $ 8.54 M | Nasdaq Global Select Market | USA |
 |
Lantheus Holdings
LNTH
|
$ 83.55 | -0.67 % | $ 5.64 B | Nasdaq Global Select Market,SPB | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | Niderland |
 |
Medpace Holdings
MEDP
|
$ 409.65 | -2.78 % | $ 11.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Biomerica
BMRA
|
$ 2.19 | 0.46 % | $ 5.03 M | Nasdaq Capital Market | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
ICON Public Limited Company
ICLR
|
$ 102.49 | -0.7 % | $ 8.45 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
$ 259.57 | -1.47 % | $ 21.6 B | NYSE,SPB | USA |
 |
NeoGenomics
NEO
|
$ 9.02 | 4.76 % | $ 1.16 B | Nasdaq Global Select Market,SPB | USA |
 |
Celcuity
CELC
|
$ 120.07 | -4.46 % | $ 5.61 B | Nasdaq Global Select Market | USA |
 |
Neogen Corporation
NEOG
|
$ 9.34 | -1.16 % | $ 2.03 B | Nasdaq Global Select Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 16.84 | -1.58 % | $ 377 M | Nasdaq Global Select Market | USA |
 |
Myriad Genetics
MYGN
|
$ 4.84 | 0.21 % | $ 448 M | Nasdaq Global Select Market,SPB | USA |
 |
Natera
NTRA
|
$ 200.17 | -2.06 % | $ 19.7 B | Nasdaq Global Select Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 195.05 | -0.8 % | $ 21.7 B | NYSE,SPB | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
 |
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | USA |
 |
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | USA |
 |
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB | USA |
 |
Precipio
PRPO
|
$ 31.75 | 3.42 % | $ 51 M | Nasdaq Global Select Market | USA |
 |
Personalis
PSNL
|
$ 5.5 | -7.72 % | $ 326 M | Nasdaq Global Select Market | USA |
 |
Senseonics Holdings
SENS
|
$ 7.18 | -1.24 % | $ 300 M | NYSE American | USA |
 |
Burning Rock Biotech Limited
BNR
|
$ 16.65 | -12.64 % | $ 179 M | Nasdaq Global Market | China |